Search - tctmd.com

Displaying 701 - 720 of 842

Sort: Relevancy | Date

News Daily News

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

L.A. McKeown

May 13, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Daily News

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

Yael L. Maxwell

March 09, 2013

News Daily News

La Lesión Miocárdica es Frecuente con la TAVR, el Pronóstico solo puede dares si está Acompañada de LRA

Yael L. Maxwell

March 09, 2013

News Industry News

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

February 27, 2013

News Industry News

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

February 12, 2013

News Daily News

Un Congreso STS Analiza un Nuevo Dispositivo TAVR y Revisa los Índices de Intervención Valvular en RU

Jason Kahn

January 28, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

Caitlin E. Cox

January 16, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

News Daily News

Los ‘10 Mejores’ Avances de 2012 según AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

Un IMC Bajo Predice los ACV y la Muerte tras una TAVR

November 28, 2012

News Daily News

Low BMI Predicts Stroke, Death After TAVR

November 28, 2012

News Industry News

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

November 15, 2012

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

News Industry News

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

October 29, 2012

Advertisement

El Bajo Riesgo de Obstrucción Coronaria Post-TAVR se asocia a Características Anatómicas Desfavorables

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Myocardial Injury Common with TAVR, Prognostic Only If Accompanied by AKI

La Lesión Miocárdica es Frecuente con la TAVR, el Pronóstico solo puede dares si está Acompañada de LRA

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

Un Congreso STS Analiza un Nuevo Dispositivo TAVR y Revisa los Índices de Intervención Valvular en RU

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Registro Europeo: Los Dispositivos TAVR revelan Resultados Similares a Corto y Largo Plazo

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Los ‘10 Mejores’ Avances de 2012 según AHA-ASA, ACC

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Un IMC Bajo Predice los ACV y la Muerte tras una TAVR

Low BMI Predicts Stroke, Death After TAVR

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

First Results from Medtronic Engager™ European Pivotal Trial Demonstrate Positive Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content